Next Generation-Targeted Amplicon Sequencing (NG-TAS): an optimised protocol and computational pipeline for cost-effective profiling of circulating tumour DNA
Year: 2019
Type: article
Abstract: Circulating tumour DNA (ctDNA) detection and monitoring have enormous potential clinical utility in oncology. We describe here a fast, flexible and cost-effective method to profile multiple genes simultaneously in low input cell-free DNA (cfDNA): Next Generation-Targeted Amplicon Sequencing (NG-TAS). We designed a panel of 377 amplicons spanning 20 cancer genes and tested the NG-TAS pipeline using cell-free DNA from two HapMap lymphoblastoid cell lines. NG-TAS consistently detected mutations in cfDNA when mutation allele fraction was > 1%. We applied NG-TAS to a clinical cohort of metastatic breast cancer patients, demonstrating its potential in monitoring the disease. The computational pipeline is available at https://github.com/cclab-brca/NGTAS_pipeline .
Source: Genome Medicine
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,680
Awards: NIHR Senior Investigator Award, Bioinformatic approaches to identify and detect both disease- and drug-related genomic alterations in breast cancer patients, NIHR Senior Investigator Award, G434337789, G6451944228, Bioinformatic approaches to identify and detect both disease- and drug-related genomic alterations in breast cancer patients, Wellcome Trust PhD Programme for Clinicians at the University of Cambridge., G7351345640, G736146644, G768266018, G8209230444
OpenAlex ID: W2884024959
